Your browser doesn't support javascript.
loading
Incapacitating solar urticaria: successful treatment with omalizumab
Kieselova, Katarina; Santiago, Felicidade; Henrique, Martinha.
  • Kieselova, Katarina; Centro Hospitalar de Leiria. Dermatology Department. Leiria. PT
  • Santiago, Felicidade; Centro Hospitalar de Leiria. Dermatology Department. Leiria. PT
  • Henrique, Martinha; Centro Hospitalar de Leiria. Dermatology Department. Leiria. PT
An. bras. dermatol ; 94(3): 331-333, May-June 2019. graf
Article in English | LILACS | ID: biblio-1011115
ABSTRACT
Abstract Solar urticaria is a rare form of physical urticaria mediated by immunoglobulin E. The lesions appear immediately after the sun exposure, interfering with the patient's normal daily life. Omalizumab, a monoclonal anti-IgE antibody, has been recently approved for the treatment of chronic spontaneous urticaria, and the latest reports support its role also in the treatment of solar urticaria. Hereby, we report a case of solar urticaria refractory to conventional treatment strategies, with an excellent response to treatment with omalizumab and phototesting normalization.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Sunlight / Urticaria / Anti-Allergic Agents / Omalizumab Type of study: Diagnostic study / Etiology study Limits: Humans / Male Language: English Journal: An. bras. dermatol Journal subject: Dermatology Year: 2019 Type: Article Affiliation country: Portugal Institution/Affiliation country: Centro Hospitalar de Leiria/PT

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Sunlight / Urticaria / Anti-Allergic Agents / Omalizumab Type of study: Diagnostic study / Etiology study Limits: Humans / Male Language: English Journal: An. bras. dermatol Journal subject: Dermatology Year: 2019 Type: Article Affiliation country: Portugal Institution/Affiliation country: Centro Hospitalar de Leiria/PT